NEW YORK — GenomeSmart said today that its GenomeBrain digital genetic test recommendation platform has been selected for pilot testing by Northern California healthcare system NorthBay Healthcare.
Launched earlier this year, GenomeBrain uses artificial intelligence to match a person's personal and medical history, as well as ethnicity and age, with national guidelines to recommended medically actionable genetic tests. The platform then generates a report that clinicians and their patients can use to determine a testing plan, according to Los Altos, California-based GenomeSmart.
Through the pilot program, NorthBay will incorporate GenomeBrain into its current workflows for breast cancer patients to help ensure they receive treatment based on genetic risk and for healthy individuals in order to expand the use of genetic testing for hereditary disease risk in routine care.
Financial and other terms of the pilot program were not disclosed.